Browsing Category
Pharma Industry News
4724 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Entropy Neurodynamics (ASX: ENP) hits TRP-8803 trial milestone as IV psilocin approach draws patient momentum
Entropy Neurodynamics (ASX: ENP) completes Cohort 1 recruitment for its TRP-8803 IV psilocin BED trial. Here's what the milestone means for investors. Read more.
Does FDA clearance across three HLA subtypes de-risk TScan Therapeutics’ platform strategy?
FDA clears TSC-102-A01 and TSC-102-A03 for TScan Therapeutics. Explore how expanded HLA reach reshapes its heme cell therapy strategy.
How FIREFLY1 data positioned Ojemda for conditional EU approval in pediatric glioma
How FIREFLY1 data positioned Ipsen’s Ojemda for conditional EU approval in pediatric glioma and what it means for investors and competitors.
Will mavorixafor’s EU path mirror its U.S. regulatory breakthrough in WHIM syndrome?
X4 Pharmaceuticals (NASDAQ: XFOR) wins EMA backing for mavorixafor. Explore what EU approval could mean for revenue, risk, and rare disease strategy.
How ALX Oncology Holdings Inc is repositioning its clinical strategy to achieve pivotal trial readiness by end-2026
ALX Oncology outlines its 2026 pivotal trial roadmap as ASPEN-09 expands and $150m funding extends runway. Read what changes next.
The drug that could dethrone Voxzogo: FDA clears Ascendis Pharma’s navepegritide alfa for achondroplasia
FDA approves Ascendis Pharma's navepegritide alfa for achondroplasia, intensifying competition with BioMarin's Voxzogo. Read what this means for the rare disease market.
Why Blue Jet Healthcare (NSE: BLUEJET) is spending Rs 1,000cr on Vizag while its stock hovers near IPO price
Blue Jet Healthcare breaks ground on Rs 1,000 crore Vizag API plant as BLUEJET stock trades near lows. What the Rs 2,300 crore expansion means for investors.
Zota Health Care (NSE: ZOTA) launches All Day Stores retail chain through Everyday Herbal Beauty Care
Zota Health Care launches All Day Stores, a 50-outlet private-label retail chain. What does this forward-integration bet mean for investors? Read the analysis.
SCY-247 intravenous trial signals strategic shift in SCYNEXIS, Inc.’s antifungal pipeline
SCYNEXIS, Inc. advances IV SCY-247 into Phase 1. Discover what this signals for antifungal resistance and hospital markets.
BioMarin Pharmaceutical (Nasdaq: BMRN) secures FDA approval to expand PALYNZIQ use in adolescents with phenylketonuria
Find out how BioMarin Pharmaceutical Inc.’s FDA approval for adolescent PALYNZIQ use could reshape PKU treatment and long-term disease control.